92 related articles for article (PubMed ID: 19106590)
1. [Efficacy of activated lymphocytes transfer therapy as a novel maker for serum granulysin level with advanced gastric cancer patients].
Kato Y; Cyon JC; Yoshimatsu K; Ogawa K
Gan To Kagaku Ryoho; 2008 Nov; 35(12):2262-4. PubMed ID: 19106590
[TBL] [Abstract][Full Text] [Related]
2. Serum granulysin level as a novel prognostic marker in patients with gastric carcinoma.
Saigusa S; Ichikura T; Tsujimoto H; Sugasawa H; Majima T; Kawarabayashi N; Chochi K; Ono S; Kinoshita M; Seki S; Ogawa K; Mochizuki H
J Gastroenterol Hepatol; 2007 Aug; 22(8):1322-7. PubMed ID: 17688669
[TBL] [Abstract][Full Text] [Related]
3. Granulysin in human serum as a marker of cell-mediated immunity.
Ogawa K; Takamori Y; Suzuki K; Nagasawa M; Takano S; Kasahara Y; Nakamura Y; Kondo S; Sugamura K; Nakamura M; Nagata K
Eur J Immunol; 2003 Jul; 33(7):1925-33. PubMed ID: 12884856
[TBL] [Abstract][Full Text] [Related]
4. Reduction in resting plasma granulysin as a marker of increased training load.
Shing CM; Ogawa K; Zhang X; Nagatomi R; Peake JM; Suzuki K; Jenkins DG; Coombes JS
Exerc Immunol Rev; 2007; 13():89-99. PubMed ID: 18198663
[TBL] [Abstract][Full Text] [Related]
5. Low-dose interleukin-2 administered pre-operatively to patients with gastric cancer activates peripheral and peritumoral lymphocytes but does not affect prognosis.
Cesana GC; Romano F; Piacentini G; Scotti M; Brenna A; Bovo G; Vaghi M; Aletti G; Caprotti R; Kaufman H; Uggeri F
Ann Surg Oncol; 2007 Apr; 14(4):1295-304. PubMed ID: 17225981
[TBL] [Abstract][Full Text] [Related]
6. Expression, processing and transcriptional regulation of granulysin in short-term activated human lymphocytes.
Latinovic-Golic S; Walch M; Sundstrom H; Dumrese C; Groscurth P; Ziegler U
BMC Immunol; 2007 Jun; 8():9. PubMed ID: 17596262
[TBL] [Abstract][Full Text] [Related]
7. [Conventional chemotherapy combined with the repetitive immune cell transfer for patients with refractory advanced gastric cancer].
Toh U; Fujii T; Mishima M; Imaizumi T; Koga A; Yano S; Shirouzu K; Yahara T; Yamana H
Gan To Kagaku Ryoho; 2007 Nov; 34(12):1931-3. PubMed ID: 18219856
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of preoperative serum levels of CEA, CA 19-9 and CA 72-4 in gastric carcinoma.
Reiter W; Stieber P; Reuter C; Nagel D; Cramer C; Pahl H; Fateh-Moghadam A
Anticancer Res; 1997; 17(4B):2903-6. PubMed ID: 9329559
[TBL] [Abstract][Full Text] [Related]
9. Induction of granulysin in CD8+ T cells by IL-21 and IL-15 is suppressed by human immunodeficiency virus-1.
Hogg AE; Bowick GC; Herzog NK; Cloyd MW; Endsley JJ
J Leukoc Biol; 2009 Nov; 86(5):1191-203. PubMed ID: 19687290
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of adoptive immunotherapy with tumor-associated lymphocytes in patients with advanced gastric cancer: a randomized trial.
Kono K; Takahashi A; Ichihara F; Amemiya H; Iizuka H; Fujii H; Sekikawa T; Matsumoto Y
Clin Cancer Res; 2002 Jun; 8(6):1767-71. PubMed ID: 12060615
[TBL] [Abstract][Full Text] [Related]
11. Analysis of serum granulysin in patients with hematopoietic stem-cell transplantation: its usefulness as a marker of graft-versus-host reaction.
Nagasawa M; Isoda T; Itoh S; Kajiwara M; Morio T; Shimizu N; Ogawa K; Nagata K; Nakamura M; Mizutani S
Am J Hematol; 2006 May; 81(5):340-8. PubMed ID: 16628730
[TBL] [Abstract][Full Text] [Related]
12. Serum TIMP-1 in gastric cancer patients: a potential prognostic biomarker.
Wang CS; Wu TL; Tsao KC; Sun CF
Ann Clin Lab Sci; 2006; 36(1):23-30. PubMed ID: 16501233
[TBL] [Abstract][Full Text] [Related]
13. Treatment of advanced gastric cancer by chemotherapy combined with autologous cytokine-induced killer cells.
Jiang J; Xu N; Wu C; Deng H; Lu M; Li M; Xu B; Wu J; Wang R; Xu J; Nilsson-Ehle P
Anticancer Res; 2006; 26(3B):2237-42. PubMed ID: 16821594
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of soluble Fas in the serum of patients with bladder cancer.
Mizutani Y; Yoshida O; Bonavida B
J Urol; 1998 Aug; 160(2):571-6. PubMed ID: 9679930
[TBL] [Abstract][Full Text] [Related]
15. [Tuberculosis in compromised hosts].
Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
[TBL] [Abstract][Full Text] [Related]
16. CD4(+)CD25(+)CD127(low/-) regulatory T cells express Foxp3 and suppress effector T cell proliferation and contribute to gastric cancers progression.
Shen LS; Wang J; Shen DF; Yuan XL; Dong P; Li MX; Xue J; Zhang FM; Ge HL; Xu D
Clin Immunol; 2009 Apr; 131(1):109-18. PubMed ID: 19153062
[TBL] [Abstract][Full Text] [Related]
17. Biological, histological, and clinical impact of preoperative IL-2 administration in radically operable gastric cancer patients.
Romano F; Cesana G; Berselli M; Gaia Piacentini M; Caprotti R; Bovo G; Uggeri F
J Surg Oncol; 2004 Dec; 88(4):240-7. PubMed ID: 15565596
[TBL] [Abstract][Full Text] [Related]
18. Search for immunomodulatory effects of blood transfusion in gastric cancer patients: flow cytometry of Th1/Th2 cells in peripheral blood.
Sun CF; Hsieh YY; Ngan KW; Wang WT
Ann Clin Lab Sci; 2001 Apr; 31(2):171-8. PubMed ID: 11337907
[TBL] [Abstract][Full Text] [Related]
19. The increase of CD57+ T cells in the peripheral blood and their impaired immune functions in patients with advanced gastric cancer.
Chochi K; Ichikura T; Majima T; Kawabata T; Matsumoto A; Sugasawa H; Kawarabayashi N; Takayama E; Hiraide H; Seki S; Mochizuki H
Oncol Rep; 2003; 10(5):1443-8. PubMed ID: 12883721
[TBL] [Abstract][Full Text] [Related]
20. Postoperative immunosuppression cascade and immunotherapy using lymphokine-activated killer cells for patients with esophageal cancer: possible application for compensatory anti-inflammatory response syndrome.
Yamaguchi Y; Hihara J; Hironaka K; Ohshita A; Okita R; Okawaki M; Matsuura K; Nagamine I; Ikeda T; Ohara M; Hamai Y
Oncol Rep; 2006 Apr; 15(4):895-901. PubMed ID: 16525677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
